This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| bacteria:t3e:xopad [2020/05/28 13:18] – lnoel | bacteria:t3e:xopad [2025/07/24 23:15] (current) – jfpothier | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== XopAD ====== | + | ====== |
| - | Author: David Studholme\\ | + | Author: |
| - | Internal reviewer: Laurent Noël\\ | + | Internal reviewer: |
| - | Expert reviewer: FIXME | + | |
| Class: XopAD\\ | Class: XopAD\\ | ||
| Family: XopAD\\ | Family: XopAD\\ | ||
| - | Prototype: XopAD (// | + | Prototypes: XAC4213 |
| - | RefSeq | + | GenBank |
| + | GenBank | ||
| + | RefSeq ID: [[https:// | ||
| 3D structure: Unknown | 3D structure: Unknown | ||
| Line 15: | Line 16: | ||
| === How discovered? === | === How discovered? === | ||
| - | XopAD was discovered using a machine-learning approach (Teper //et al//., 2016). | + | XopAD was first described as a homologue of a type 3 effector from //Ralstonia solanacearum// |
| === (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
| XopAD fused to the AvrBs2 reporter domain, was shown to translocate into plant cells in an // | XopAD fused to the AvrBs2 reporter domain, was shown to translocate into plant cells in an // | ||
| + | |||
| === Regulation === | === Regulation === | ||
| - | Not known. | + | No PIP box was found in the promoter region of //xopAD// in //X. euvesicatoria// |
| + | |||
| + | qRT-PCR revealed that transcript levels of 15 out of 18 tested non-TAL effector genes (as well as the regulatory genes //hrpG// and //hrpX//), including //xopAD//, were significantly reduced in the // | ||
| === Phenotypes === | === Phenotypes === | ||
| - | Deletion of //xopAD// does not alter //X. citri// pv. // | + | Deletion of //xopAD// does not alter //X. citri// pv. //citri// pathogenicity (Escalon //et al.//, 2013). |
| === Localization === | === Localization === | ||
| Line 31: | Line 38: | ||
| === Enzymatic function === | === Enzymatic function === | ||
| - | Not known. However, | + | Not known. However, the 614 amino acid protein consists of multiple [[https:// |
| === Interaction partners === | === Interaction partners === | ||
| Line 40: | Line 48: | ||
| === In xanthomonads === | === In xanthomonads === | ||
| - | Yes. XopAD has homologues encoded in the genomes of most // | + | Yes. XopAD has homologues encoded in the genomes of most // |
| === In other plant pathogens/ | === In other plant pathogens/ | ||
| - | Yes. XopAD is homologous to members of the RipS1 family of effectors in //Ralstonia solanacearum// | + | Yes. XopAD is homologous to members of the RipS1 family of effectors in //Ralstonia solanacearum// |
| ===== References ===== | ===== References ===== | ||
| - | Escalon A //et al.// (2013). Variations in type III effector repertoires, | + | Escalon A, Javegny S, Vernière C, Noël LD, Vital K, Poussier S, Hajri A, Boureau T, Pruvost O, Arlat M, Gagnevin L (2013). Variations in type III effector repertoires, |
| + | |||
| + | Harrison J, Studholme DJ (2014). Draft genome sequence of // | ||
| + | |||
| + | Liu Y, Long J, Shen D, Song C (2016). // | ||
| + | |||
| + | Peeters N, Carrère S, Anisimova M, Plener L, Cazalé AC, Genin S (2013). Repertoire, unified nomenclature and evolution of the type III effector gene set in the //Ralstonia solanacearum// | ||
| + | |||
| + | Studholme DJ, Kemen E, MacLean D, Schornack S, Aritua V, Thwaites R, Grant M, Smith J, Jones JD (2010). Genome-wide sequencing data reveals virulence factors implicated in banana // | ||
| - | Harrison J & Studholme DJ (2014). Draft genome sequence | + | Teper D, Burstein D, Salomon D, Gershovitz M, Pupko T, Sessa G (2016). Identification |
| - | Peeters N //et al.// (2013). Repertoire, unified nomenclature and evolution | + | Vicente JG, Rothwell S, Holub EB, Studholme DJ (2017). Pathogenic, phenotypic and molecular characterisation of //Xanthomonas nasturtii// sp. nov. and //Xanthomonas floridensis// |
| - | Studholme DJ //et al.// (2010). Genome-wide sequencing | + | Wasukira A, Tayebwa J, Thwaites R, Paszkiewicz K, Aritua V, Kubiriba J, Smith J, Grant M, Studholme DJ (2012). Genome-wide sequencing reveals |
| - | Teper D //et al.// (2016). Identification | + | White FF, Potnis N, Jones JB, Koebnik R (2009). The type III effectors |
| - | Vicente JG, Rothwell S, Holub EB, Studholme DJ (2017). Pathogenic, phenotypic and molecular characterisation of // | + | ===== Acknowledgements ===== |
| - | Wasukira A //et al.// (2012). Genome-wide sequencing reveals two major sub-lineages | + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation |